• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Medulloblastoma

Medulloblastoma - 41 Studies Found

Recruiting : WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
:
  • Childhood Central Nervous System Neoplasm
  • Recurrent Childhood Medullob
    : 2014-03-13
    :
    • Drug: Irinotecan Hydrochloride

Recruiting : Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
: Brain and Central Nervous System Tumors
: 2006-01-12
:
  • Drug: cisplatin
  • Drug: lomustine

Completed : Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
:
  • Brain Tumors
  • Central Nervous System Tumors

: 1999-11-01
:
  • Biological: filgrastim Other N

Completed : Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
:
  • Brain Tumors
  • Central Nervous System Tumors

: 1999-11-01
:
  • Biological: filgrastim Other N

Completed : Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
:
  • Lymphoma
  • Childhood Lymphoma
  • Solid Tumor
  • Drug: Genistein Estrogen-like

Active, not recruiting : Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
: Brain and Central Nervous System Tumors
: 2003-04-07
:
  • Drug: cisplatin
  • Drug: lomustine

Completed : Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors
: Brain and Central Nervous System Tumors
: 2001-10-11
:
  • Biological: filgrastim
  • Drug: carboplatin

Completed : A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
: Medulloblastoma
: 2025-08-05
: Given IV
COMPLETED : Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
: Medulloblastoma
: 2025-08-05
: Given IV
COMPLETED : Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
: Medulloblastoma
: 2025-08-05
: TTRNA-xALT 3 x 10^7/kg by intravenous injection once.
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.